For decades, the expectation that new drugs would prove effective in two independent, adequate, and well-controlled clinical trials served as an insurance against patient exposure. This approach meant repeating the finding before the drugs were approved. It wasn't perfect. Speed is seductive, but the certainty of a clinical trial is slower.